Cáncer renal subgrupos de pacientes y poblaciones especiales: ¿qué hemos aprendido? - page 73

Everolimus Versus Sunit inib Prospective Evaluation in

Metastatic Non–Clear Cel l Renal Cell Carcinoma (ESPN):

A Randomized Multicenter Phase 2 Trial

PFS:

6.1 mo SU vs 4.1 EV

OS:

16.1 mo SU vs 14.1 EV

Tannir NM, et al. Eur Urol 2016;69:866‐74

SEO Version

Warning.

You are currently viewing the SEO version of !text.
It has a number of design and functionality limitations.

We recommend viewing the Flash version or the basic HTML version of this publication.

1...,63,64,65,66,67,68,69,70,71,72 74,75,76,77,78,79,80,81,82,83,...84